Improvement of the Degradation Profiling of Eculizumab and Omalizumab Monoclonal Antibodies by Liquid Chromatography–Mass Spectrometry
Crossref DOI link: https://doi.org/10.1134/S1061934821140033
Published Online: 2021-12-22
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Degterev, M.
Smolov, M.
Shukurov, R.
Text and Data Mining valid from 2021-12-01
Version of Record valid from 2021-12-01
Article History
Received: 5 October 2020
Revised: 14 December 2020
Accepted: 14 December 2020
First Online: 22 December 2021